• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predictors of outcomes in patients with ascites, hyponatremia, and renal failure.

作者信息

Asrani Sumeet K, Kamath Patrick S

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN.

Baylor University Medical Center, Dallas, TX.

出版信息

Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):132-135. doi: 10.1002/cld.203. eCollection 2013 Jun.

DOI:10.1002/cld.203
PMID:30992845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448637/
Abstract
摘要

相似文献

1
Predictors of outcomes in patients with ascites, hyponatremia, and renal failure.腹水、低钠血症和肾衰竭患者预后的预测因素。
Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):132-135. doi: 10.1002/cld.203. eCollection 2013 Jun.
2
The management of ascites and hyponatremia in cirrhosis.肝硬化腹水和低钠血症的管理
Semin Liver Dis. 2008 Feb;28(1):43-58. doi: 10.1055/s-2008-1040320.
3
[Refractory ascites and dilutional hyponatremia: current management and new aquaretics].[难治性腹水与稀释性低钠血症：当前治疗及新型利水药物]
Rev Gastroenterol Mex. 2005 Jul-Sep;70(3):299-311.
4
Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.口服米索前列醇或静脉注射前列腺素E2并不能改善肝硬化腹水合并低钠血症或肾衰竭患者的肾功能。
J Hepatol. 1993 Feb;17(2):220-6. doi: 10.1016/s0168-8278(05)80042-x.
5
Dilutional hyponatremia in patients with cirrhosis and ascites.
Arch Intern Med. 2002 Feb 11;162(3):323-8. doi: 10.1001/archinte.162.3.323.
6
Correction of Hyponatremia May Be a Treatment Stratification Biomarker: A Two-Stage Systematic Review and Meta-Analysis.低钠血症的纠正可能是一种治疗分层生物标志物：两阶段系统评价和荟萃分析
J Clin Med. 2018 Sep 7;7(9):262. doi: 10.3390/jcm7090262.
7
Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites.严重低钠血症是肝硬化伴难治性腹水患者死亡率的更好预测指标，优于 MELDNa。
J Hepatol. 2012 Aug;57(2):274-80. doi: 10.1016/j.jhep.2012.03.018. Epub 2012 Apr 17.
8
[Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].[肝硬化腹水、低钠血症及肝肾综合征的治疗]
Ther Umsch. 2009 Nov;66(11):747-51. doi: 10.1024/0040-5930.66.11.747.
9
[Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].[肝硬化无低钠血症及肾功能不全患者腹水的治疗。比较利尿剂与白蛋白补偿穿刺术的随机研究结果]
Gastroenterol Clin Biol. 1992;16(10):751-5.
10
Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.腹水与稀释性低钠血症的病理生理学：利水药物的当代应用
Ann Hepatol. 2007 Oct-Dec;6(4):214-21.

本文引用的文献

1
Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome.急性肾损伤病因对肝移植后结局的影响：急性肾小管坏死与肝肾综合征。
Liver Transpl. 2012 May;18(5):539-48. doi: 10.1002/lt.23384.
2
Renal failure and cirrhosis: a systematic review of mortality and prognosis.肾衰竭和肝硬化：死亡率和预后的系统评价。
J Hepatol. 2012 Apr;56(4):810-8. doi: 10.1016/j.jhep.2011.10.016. Epub 2011 Dec 13.
3
All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study.
肝硬化患者与普通人群的全因死亡率比较：基于人群的队列研究。
Liver Int. 2012 Jan;32(1):79-84. doi: 10.1111/j.1478-3231.2011.02517.x. Epub 2011 Apr 6.
4
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.终末期肝病模型修订版优化了肝移植等待患者死亡率的预测。
Gastroenterology. 2011 Jun;140(7):1952-60. doi: 10.1053/j.gastro.2011.02.017. Epub 2011 Feb 18.
5
Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score.低肌酐水平的肝移植候选者中肌氨酸酐和肌氨酸酐为基础的公式的不准确性：对终末期肝病模型评分的影响。
Liver Transpl. 2010 Oct;16(10):1169-77. doi: 10.1002/lt.22128.
6
Prognostic importance of the cause of renal failure in patients with cirrhosis.肝硬化患者肾衰竭病因的预后意义。
Gastroenterology. 2011 Feb;140(2):488-496.e4. doi: 10.1053/j.gastro.2010.07.043. Epub 2010 Aug 1.
7
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.肝硬化患者的感染会使死亡率增加四倍，应将其用于判断预后。
Gastroenterology. 2010 Oct;139(4):1246-56, 1256.e1-5. doi: 10.1053/j.gastro.2010.06.019. Epub 2010 Jun 14.
8
Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.酒精性肝硬化的临床病程：一项丹麦基于人群的队列研究。
Hepatology. 2010 May;51(5):1675-82. doi: 10.1002/hep.23500.
9
Serum sodium, renal function, and survival of patients with end-stage liver disease.血清钠、肾功能与终末期肝病患者的生存。
J Hepatol. 2010 Apr;52(4):523-8. doi: 10.1016/j.jhep.2010.01.009. Epub 2010 Feb 4.
10
Renal failure in cirrhosis.肝硬化中的肾衰竭
N Engl J Med. 2009 Sep 24;361(13):1279-90. doi: 10.1056/NEJMra0809139.